CAS: 51804-69-4; 6-Hydroxy-3,4,7,8-Tetramethoxy-12-Methyl-5,6,7,8,9,10-Hexahydro-8A,4B-(Epiminoethano)-8,10-Epoxyphenanthren-13-One

该化合物是一个复杂的有机化合物,其独特的结构特征具有其独特性能,包括多种甲氧组和特定的立体化学特性.该化合物属于类藻类,以其不同的生物活动闻名.环氧组的存在表明其具有潜在的再活动性,使它成为各种化学变异的候选体.氢氧基组有助于其极性,影响其在不同溶剂中的溶性.混合氧组加强了其亲性,这可能影响其与生物膜的相互作用.此外,这些组合表明的具体立体化学学可能在其生物活动和药理特性方面发挥关键作用.

结构式图片

MSDS等安全信息

    上下游产品

    Oxoepistephamiersin 8β,10β-epoxy-3,4,7α,8α-tetramethoxy-17-methyl-hasubanan-6-one 8β,10β-epoxy-3,4,7β,8α-tetramethoxy-17-methyl-hasubanan-6-one

    合成工艺路线路线简述

      📜Stephamiersin置于sodium Hydroxide,Sodium Tetrahydroborate,Potassium Permanganate,Magnesium Sulfate体系中,用 甲醇,水,丙酮 作为反应溶剂,化学反应生成 二氢氧代表千金藤默星碱
      参考文献:Constitution Of Four New Hasubanan Alkaloids From Stephania Japonica Miers.
      标题:Constitution Of Four New Hasubanan Alkaloids From Stephania Japonica Miers.
      摘要:Four New Hasubanan Alkaloids,Stephamiersine (1),Epistephamiersine (2),Oxostephamiersine (3) And Stephasunoline (4) Were Isolated Together With Seven Known And Three Unidentified Alkaloids From Stephania Japonica Miers (Menispermaceae). Among These New Alkaloids,1 And 2 Were Found To Be Epimeric Isomers With Respect To The C-7 Methoxyl Group. Permanganate Oxidation Of 1 Gave 3,And Borohydride Reduction Of 1 And 2 Gave The Highly Stereoselective Products,Dihydrostephamiersine (6) And Dihydroepistephamiersine (5). On Mild Treatment Of 5 With Hydrochloric Acid Gave 4. Acetolyses Of 1,2,5 And 6 Gave The Phenanthrene Derivatives,7,8 And 9,Respectively. Further,Both 1 And 2 Were Converted To The Conjugated Carbonyl Compound (14) Which Was Obtained From Dihydro-16-Oxohasubanonine (17A) (17B). On The Other Hand,The Stereochemistry Of 1,2,3 And 4 Was Elucidated By Nuclear Magnetic Resonance (NMR) Spectroscopic Studies As Follows : The C-7 Methoxyl Group Of 1 Has The α-Axial And That Of 2 And 4 Has The β-Equatorial Configuration,And The Hydroxyl Group Of 4 Has The β-Axial One. On The Basis Of The Above Chemical Correlation Coupled With The Spectral Arguments,The Constitution Of The New Alkaloids Was Represented As Drawn In The Formulas,1,2,3 And 4.
      DOI:10.1248/cpb.23.1323

      海关参考信息

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献

      合成方法参考DOI号:10.1248/cpb.23.1323
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知